Adjuvant Chemotherapy for Colon Cancer

Dis Colon Rectum. 2019 Mar;62(3):274-278. doi: 10.1097/DCR.0000000000001328.

Abstract

A 55-year-old man with no medical history presents to his primary care physician with fatigue and dark stools and is found to have anemia. He is referred for diagnostic colonoscopy and found to have an ulcerated mass in the ascending colon. Metastatic workup is negative. He is referred to a colorectal surgeon and undergoes an uneventful laparoscopic right hemicolectomy. Final pathology reveals a 4-cm ulcerated mass involving the muscularis propria with 3 positive lymph nodes out of 12 (T2N1bM0, stage IIIA). The patient arrives at his postoperative appointment with questions about chemotherapy.

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural

MeSH terms

  • Algorithms
  • Antineoplastic Agents* / administration & dosage
  • Antineoplastic Agents* / adverse effects
  • Antineoplastic Agents* / classification
  • Chemotherapy, Adjuvant* / methods
  • Chemotherapy, Adjuvant* / standards
  • Colectomy / methods
  • Colonic Neoplasms* / drug therapy
  • Colonic Neoplasms* / mortality
  • Colonic Neoplasms* / pathology
  • Colonic Neoplasms* / surgery
  • Female
  • Humans
  • Male
  • Medical Oncology / education*
  • Middle Aged
  • Neoplasm Staging
  • Patient Care Management / methods*
  • Patient Selection
  • Prognosis
  • Randomized Controlled Trials as Topic
  • Risk Assessment
  • Survival Rate

Substances

  • Antineoplastic Agents